Christian Lehermayr

Associate Director Science & Technology at Novartis Pharma AG in the scientific office of biologics drug product development in Austria/EU - 12 years biologics late stage development experience. Current focus: clinical in-use testing, manual and automated visual inspection, protein particle root cause investigations, and transport stress simulation) till 2011 PhD on physico-chemical characterization of mAbs at F.Hoffmann-La Roche AG and Martin-Luther University Halle-Wittenberg. till 2008 Diploma Thesis on mAb DSP and formulation development at MorphoSys AG